# Desmopressin Response in the Young

> **NCT00230594** · PHASE3 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 132 (actual)

## Conditions studied

- Primary Nocturnal Enuresis

## Interventions

- **DRUG:** desmopressin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00230594
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2006-01
- **Final completion:** 2006-02
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2011-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00230594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00230594, "Desmopressin Response in the Young". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00230594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*